The study is being conducted to evaluate the efficacy, and safety of HR18034 for postoperative analgesia in subjects undergoing hemorrhoidectomy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
294
HR18034 380mg
ropivacaine HCl 75mg.
Sodium Chloride Physiological Solution 20ml
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
AUC of Pain Intensity in rest state
Pain intensity will be evaluated using an 11-point (0-10) Numeric Pain Rating Scale (NPRS), with higher numbers indicating a higher pain intensity, administered over 72 hours.
Time frame: 0~72 hours after administration
Proportion of subjects with Pain Rating Scale (NPRS)≥4 during dressing change
Time frame: 0~72 hours after administration
Proportion of subjects with Pain Rating Scale (NPRS)≥4 during defecation
Time frame: 0~72 hours after administration
AUC of Pain Intensity in rest state
Time frame: 0~24 hours after administration
AUC of Pain Intensity in move state
Time frame: 0~24 hours,0~72 hours after administration
Proportion of subjects who doesn't recive rescue analgesic
Time frame: 0~72 hours after administration
Participant's satisfaction score for analgesia treatment
Time frame: 72-hours
Investigator's satisfaction score for analgesia treatment
Time frame: 72-hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.